Faculty Experts

Alexandros Makriyannis

George D. Behrakis Chair in Pharmaceutical Biotechnology, Director of the Center for Drug Discovery

Contact

a.makriyannis@neu.edu
617.373.4200

Related Articles

An interdisciplinary approach to drug-​​abuse research

The Center for Drug Dis­covery at North­eastern hosted the 10th annual sym­po­sium on cur­rent trends in drug-​​abuse research ear­lier this month.

Alexandros Makriyannis

Professor honored for his contributions to medicinal chemistry

Alexan­dros Makriyannis, the founding director of Northeastern’s Center for Drug Dis­covery, has received the annual Award in Med­i­c­inal Chem­istry from the Amer­ican Chem­ical Society.

Makriyannis

Northeastern explores biotech collaboration with Algeria

A del­e­ga­tion of Algerian gov­ern­ment offi­cials met last week with Pres­i­dent Joseph E. Aoun and fac­ulty mem­bers in the Bouvé Col­lege of Health Sci­ences with the hope of forging part­ner­ships in the biotech­nology sector.

Photo by Christopher Huang.

New weight-​​loss compound shows promise

Northeastern’s Center for Drug Dis­covery col­lab­o­rates with National Insti­tutes of Health on a ther­a­peutic drug that could aid weight loss without side effects

Pharmaceutical Biotech Scientist Discovers New Molecule to Treat Chronic Pain

North­eastern Uni­ver­sity Phar­ma­ceu­tical Sci­ences pro­fessor and Center for Drug Dis­covery director Alexan­dros Makriyannis and a team of researchers have cre­ated a syn­thetic mol­e­cule that could be used to treat chronic … read more »

Selected Publications

For a complete list of faculty citations, please visit iRis, Northeastern’s digital archive.

Paper

Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma

(with Wood J.T., J.S. Williams, L. Pandarinathan, D.R. Janero, and C.J. Lammi-Keefe) J. Lipid Res., 51(6), 1416-1423.

Paper

Mass spectrometry-based GPCR proteomics: Comprehensive characterization of the human cannabinoid 1 receptor

(with Zvonok N., W. Xu, J. Williams, D.R. Janero, and S.C. Krishnan) J. Proteome Res., 9(4), 1746-1753.

Paper

The neutral cannabinoid CB(1) receptor antagonist AM4113 regulates body weight through changes in energy intake in the rat

(with Cluny N.L., A.P. Chambers, V.K. Vemuri, J.T. Wood, L.K. Eller, C. Freni, R.A. Reimer, and K.A. Sharkey) Pharmacol. Biochem. Behav., 97(3), 537-543.

About news@Northeastern

News@Northeastern is Northeastern University's primary source of news and information. Whether it happens in the classroom, in a laboratory, or on another continent, we bring you timely stories about every aspect of life, learning and discovery at Northeastern. Contact the news team

Subscribe to daily news email

Connect with us

Social Media Dashboard